EricRoelandMDFAAHPM, FASCO(He/Him)

Oncology • Portland, OR

Gastrointestinal Cancer, Hospice & Palliative

Oregon Health and Science University

Join to view full profile

Dr. Roeland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Roeland's full profile

Already have an account?

Office
Division of Hematology and Medical Oncology
3181 SW Sam Jackson Park Road, OC14HO
Portland, OR 97239
Phone+1 503-494-8534

Summary

Eric Roeland, MD, FAAHPM, FASCO, is an Associate Professor at the Oregon Health and Science University. He is a medical oncologist and palliative care specialist whose clinical practice focuses on caring for adults with cancer experiencing poorly controlled symptoms. As the Director of the Knight Cancer Institute Symptom Science Clinical Research Program, his research focuses on Symptom Science, characterizing symptoms' phenotypes and biological underpinnings to develop effective novel clinical interventions to inform clinical practice. He has participated in many industry- and grant-sponsored clinical trials spanning the last decade and has first-hand experience conducting supportive oncology clinical trials.

Education & Training

University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Scripps Mercy HospitalFellowship, Hospice and Palliative Medicine, 2008 - 2009
University of California (San Diego) Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Colorado School of Medicine Anschutz Medical CampusClass of 2005

Certifications & Licensure

CA State Medical License 2007 - Present
OR State Medical License 2021 - 2025
WA State Medical License 2023 - 2025
MA State Medical License 2018 - 2022
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 Start of enrollment: 2022 Nov 21
Active, not recruiting
Phase 2
Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy Start of enrollment: 2020 Oct 07
Active, not recruiting
Phase 3
A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer Start of enrollment: 2011 Dec 01
Completed
Phase 2
A Phase 1 Study of LY2787106 in Cancer and Anemia Start of enrollment: 2010 Jan 01
Completed
Phase 1
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) Start of enrollment: 2011 Jun 24
Completed
Phase 3
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) Start of enrollment: 2011 Jul 01
Completed
Phase 3
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) Start of enrollment: 2011 Jul 01
Completed
Phase 3
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer Start of enrollment: 2013 Mar 31
Terminated
Phase 3
A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer Start of enrollment: 2012 Sep 01
Completed
Phase 1, Phase 2
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies Start of enrollment: 2011 May 01
Completed
Not Applicable
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors Start of enrollment: 2021 Sep 13
Recruiting
Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients Start of enrollment: 2022 Mar 24
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

11 citations
Case Report: Efficacy and Tolerability of Ketamine in Opioid-Refractory Cancer Pain
Priya Amin, Eric Roeland, Rabia S. Atayee
Journal of Pain & Palliative Care Pharmacotherapy. 2014-08-28
156 citations
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.
Aparna Raj Parikh, Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich
Clinical Cancer Research. 2021-04-29
1 citations
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.
Lee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, Rebecca Clark-Snow
Supportive Care in Cancer. 2023-10-25

Press Mentions

Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)November 4th, 2024
Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)November 4th, 2024
New OHSU Study Shows Promise in Treating ‘Urgent, Unmet Need’ in Cancer PatientsSeptember 20th, 2024
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Fellow
American Academy of Hospice and Palliative Medicine - AAHPM
Fellow
Multinational Association of Supportive Care in Cancer
Member

Other Languages

Spanish

External Links

OHSUhttps://www.ohsu.edu/providers/eric-roeland-md-faahpm
Linkedinhttps://www.linkedin.com/in/eric-roeland-md-faahpm-fasco-82260348/
Pubmedhttps://www.ncbi.nlm.nih.gov/myncbi/1zwfFBrbja8km/bibliography/public/